Table 1.
Clinicopathological parameters | Controls | Cases | p-value |
---|---|---|---|
Age | |||
≥51 | 22 (55%) | 44 (77%) | 0.02 |
≤50 | 18 (45%) | 13 (28%) | |
Gender | |||
Males | 30 (75%) | 41 (71.9%) | 0.37 |
Females | 10 (25%) | 16 (28.07%) | |
Smoking status | |||
Yes | 4 (10%) | 33 (57%) | <0.01 |
No | 36 (90%) | 24 (42.1%) | |
Histopathology | |||
Poorly differentiated adenocarcinoma | – | 23 (40.35%) | |
Moderately differentiated adenocarcinoma | – | 20 (35.08%) | |
Well-differentiated adenocarcinoma | – | 7 (12.28%) | |
Others | – | 7 (12.28%) | |
TNM staging | |||
Stage I | – | 5 (8.7%) | |
Stage II | – | 19 (33.33%) | |
Stage III | – | 33 (57.89%) | |
Life style | |||
Active | 32 (80%) | 50 (87.7%) | 0.27 |
Sedentary | 8 (20%) | 7 (12.28%) | |
Demography | |||
Rural | 15 (37.5%) | 47 (82.45%) | <0.01 |
Urban | 25 (62.5%) | 10 (17.54%) |
The bold values represents that they are statistically significant.